You just read:

Foresee Announces Successful Completion of Scientific Advice Discussions with German Federal Institute for Drugs and Medical Devices (BfArM) for FP-001 LMIS 50 mg

News provided by

Foresee Pharmaceuticals Co., Ltd.

06 Feb, 2017, 06:59 ET